PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33720612-6	2020	Umifenovir is antiviral agent, it belongs to fusion inhibitors, interacts with SARS-CoV-2 spike protein.	umifenovir	0-10	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	90-95	
33750821-3	2021	The endosomal acidification inhibitors (8P9R and chloroquine) can synergistically enhance the activity of arbidol, a spike-ACE2 fusion inhibitor, against SARS-CoV-2 and SARS-CoV in cells.	umifenovir	106-113	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	117-122	
33688584-3	2021	Comparing to those under trial/temporarily used antivirus drugs (i.e., umifenovir, lopinavir), ceftriaxone, cefotaxime, and cefuroxime show higher binding affinities to the N-terminal domain of N protein (N-NTD), C-terminal domain of N protein (N-CTD), and receptor-binding domain of S protein (S-RBD).	umifenovir	71-81	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	284-285	
32955901-7	2020	RESULTS AND CONCLUSION: The similarity between hemagglutinin and spike proteins were reported due to the fact that inhibition properties of Arbidol and its 39 analogues were examined in detail against hemagglutinin esterase and spike glycoproteins.	umifenovir	140-147	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	65-70	
32955901-7	2020	RESULTS AND CONCLUSION: The similarity between hemagglutinin and spike proteins were reported due to the fact that inhibition properties of Arbidol and its 39 analogues were examined in detail against hemagglutinin esterase and spike glycoproteins.	umifenovir	140-147	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	228-233	
32955901-9	2020	The interaction mechanism was clarified between arbidol and spike proteins.	umifenovir	48-55	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	60-65	
32955901-10	2020	Phenylalanine, tyrosine, glycine, lysine, and aspartic acid were found to be the headliner amino acids in the interactions between Arbidol and binding domains of spike glycoproteins in the SARS-CoV2 (Tab.	umifenovir	131-138	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	162-167	
34898207-0	2021	Modeling the Structure-Activity Relationship of Arbidol Derivatives and Other SARS-CoV-2 Fusion Inhibitors Targeting the S2 Segment of the Spike Protein.	umifenovir	48-55	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	139-144